Dr. Antoine (Tony) Noujaim
Director and Past Chairman of the Board
Dr. Noujaim holds a doctorate in bionucleonics from Purdue University. He has been Chairman of the board of AltaRex Inc. (a public biopharmaceutical company listed on the Toronto Stock Exchange “TSE”), from November, 1995 to July 2002. Dr. Noujaim also served as President and Chief Executive Officer of AltaRex Inc. from November, 1995 to February, 1998. From 1999 to present, Dr. Noujaim has been a Director of Oncolytic Biotech Inc., a company currently trading on the TSE. From 1994 to 1999, Dr. Noujaim was a Director of Synsorb Inc., a company trading on NASDAQ and the TSE. Both Oncolytic Biotech Inc. and Synsorb Inc. are Canadian biopharmaceutical companies based in Calgary, Alberta. Prior to the formation of AltaRex Inc., Dr. Noujaim was the President of Biomira Research Inc., a division of Biomira Inc., a public biopharmaceutical company trading on NASDAQ and the TSE, which Dr. Noujaim helped found. From 1985 to 1995, he was Senior Vice President and Chief Operating Officer of the Immunoconjugate Division of Biomira Inc. For the past five years, Dr. Noujaim has been serving as Chairman of the Board and President of Noustar Technologies Inc., a technology venture capital company which is 100% owned by Dr. Noujaim. Dr. Noujaim is also a significant shareholder in and Chairman of the Board of Novolytic Corp., an Edmonton based private biotechnology company dealing with cancer research and development. Dr. Noujaim is formerly the President and currently a director of the Alberta Biotechnology Association and serves on boards of directors of several knowledge-based companies.
